These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1992687)

  • 1. Inhibition of pulmonary surfactant function by meconium.
    Moses D; Holm BA; Spitale P; Liu MY; Enhorning G
    Am J Obstet Gynecol; 1991 Feb; 164(2):477-81. PubMed ID: 1992687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphology and function of pulmonary surfactant inhibited by meconium.
    Bae CW; Takahashi A; Chida S; Sasaki M
    Pediatr Res; 1998 Aug; 44(2):187-91. PubMed ID: 9702912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of different surfactant preparations to inactivation by meconium.
    Herting E; Rauprich P; Stichtenoth G; Walter G; Johansson J; Robertson B
    Pediatr Res; 2001 Jul; 50(1):44-9. PubMed ID: 11420417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surfactant inhibition in experimental meconium aspiration.
    Sun B; Curstedt T; Robertson B
    Acta Paediatr; 1993 Feb; 82(2):182-9. PubMed ID: 8477165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipase A2 is present in meconium and inhibits the activity of pulmonary surfactant: an in vitro study.
    Schrama AJ; de Beaufort AJ; Sukul YR; Jansen SM; Poorthuis BJ; Berger HM
    Acta Paediatr; 2001 Apr; 90(4):412-6. PubMed ID: 11332933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of meconium inhibition of pulmonary surfactant by ferric chloride, copper chloride, and acetic acid.
    Almaas R; Robertson B; Linderholm B; Lundberg E; Saugstad OD; Moen A
    Am J Respir Crit Care Med; 2000 Nov; 162(5):1789-94. PubMed ID: 11069814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dextran reduces surfactant inhibition by meconium.
    Tashiro K; Kobayashi T; Robertson B
    Acta Paediatr; 2000 Dec; 89(12):1439-45. PubMed ID: 11195233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonionic polymers reverse inactivation of surfactant by meconium and other substances.
    William Taeusch H; Lu KW; Goerke J; Clements JA
    Am J Respir Crit Care Med; 1999 May; 159(5 Pt 1):1391-5. PubMed ID: 10228100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro effect of meconium on the physical surface properties and morphology of exogenous pulmonary surfactant.
    Park KH; Bae CW; Chung SJ
    J Korean Med Sci; 1996 Oct; 11(5):429-36. PubMed ID: 8934399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of pulmonary surfactant by oleic acid: mechanisms and characteristics.
    Hall SB; Lu RZ; Venkitaraman AR; Hyde RW; Notter RH
    J Appl Physiol (1985); 1992 May; 72(5):1708-16. PubMed ID: 1601776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of meconium on pulmonary surfactant function tested in vitro using the stable microbubble test.
    Oh MH; Bae CW
    Eur J Pediatr; 2000 Oct; 159(10):770-4. PubMed ID: 11039134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological alterations of exogenous surfactant inhibited by meconium can be prevented by dextran.
    Ochs M; Schüttler M; Stichtenoth G; Herting E
    Respir Res; 2006 Jun; 7(1):86. PubMed ID: 16756655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure to polymers reverses inhibition of pulmonary surfactant by serum, meconium, or cholesterol in the captive bubble surfactometer.
    López-Rodríguez E; Ospina OL; Echaide M; Taeusch HW; Pérez-Gil J
    Biophys J; 2012 Oct; 103(7):1451-9. PubMed ID: 23062337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral cell wall lipids of Mycobacterium tuberculosis are inhibitory to surfactant function.
    Wang Z; Schwab U; Rhoades E; Chess PR; Russell DG; Notter RH
    Tuberculosis (Edinb); 2008 May; 88(3):178-86. PubMed ID: 18155644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of pulmonary surfactant function by phospholipases.
    Holm BA; Keicher L; Liu MY; Sokolowski J; Enhorning G
    J Appl Physiol (1985); 1991 Jul; 71(1):317-21. PubMed ID: 1917756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of hemoglobin and cell membrane lipids on pulmonary surfactant activity.
    Holm BA; Notter RH
    J Appl Physiol (1985); 1987 Oct; 63(4):1434-42. PubMed ID: 3693177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations.
    Seeger W; Grube C; Günther A; Schmidt R
    Eur Respir J; 1993 Jul; 6(7):971-7. PubMed ID: 8370446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surfactant function in respiratory distress syndrome.
    Ikegami M; Jacobs H; Jobe A
    J Pediatr; 1983 Mar; 102(3):443-7. PubMed ID: 6687477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema.
    Günther A; Siebert C; Schmidt R; Ziegler S; Grimminger F; Yabut M; Temmesfeld B; Walmrath D; Morr H; Seeger W
    Am J Respir Crit Care Med; 1996 Jan; 153(1):176-84. PubMed ID: 8542113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biophysical properties of protein-free, totally synthetic pulmonary surfactants, ALEC and Exosurf, in comparison with surfactant TA.
    Takahashi A; Nemoto T; Fujiwara T
    Acta Paediatr Jpn; 1994 Dec; 36(6):613-8. PubMed ID: 7871968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.